PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,605,000 | -10.2% | 142,579 | -4.8% | 0.01% | -16.7% |
Q3 2016 | $5,126,000 | +12.2% | 149,803 | +10.6% | 0.01% | 0.0% |
Q2 2016 | $4,569,000 | -31.7% | 135,455 | +7.3% | 0.01% | -33.3% |
Q1 2016 | $6,689,000 | -29.0% | 126,249 | +2.9% | 0.01% | -25.0% |
Q4 2015 | $9,417,000 | +87.0% | 122,637 | +0.1% | 0.01% | +71.4% |
Q3 2015 | $5,035,000 | -42.5% | 122,502 | -1.0% | 0.01% | -36.4% |
Q2 2015 | $8,750,000 | +0.1% | 123,726 | +25.8% | 0.01% | 0.0% |
Q1 2015 | $8,742,000 | +1.7% | 98,388 | +1.5% | 0.01% | 0.0% |
Q4 2014 | $8,596,000 | -12.2% | 96,960 | -4.0% | 0.01% | -21.4% |
Q3 2014 | $9,787,000 | +9.4% | 100,976 | +3.7% | 0.01% | +16.7% |
Q2 2014 | $8,948,000 | +68.1% | 97,407 | +28.1% | 0.01% | +50.0% |
Q1 2014 | $5,323,000 | +22.3% | 76,060 | +0.4% | 0.01% | +33.3% |
Q4 2013 | $4,354,000 | +16.5% | 75,733 | -2.5% | 0.01% | 0.0% |
Q3 2013 | $3,736,000 | +77.1% | 77,702 | +6.8% | 0.01% | +50.0% |
Q2 2013 | $2,110,000 | – | 72,765 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |